20-2816571-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001167670.3(TMEM239):c.17G>A(p.Arg6Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000045 in 1,510,990 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001167670.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM239 | NM_001167670.3 | c.17G>A | p.Arg6Gln | missense_variant | 2/2 | ENST00000380585.2 | NP_001161142.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM239 | ENST00000380585.2 | c.17G>A | p.Arg6Gln | missense_variant | 2/2 | 1 | NM_001167670.3 | ENSP00000369959 | P1 | |
TMEM239 | ENST00000361033.1 | c.146G>A | p.Arg49Gln | missense_variant | 2/2 | 2 | ENSP00000354312 |
Frequencies
GnomAD3 genomes AF: 0.0000673 AC: 10AN: 148692Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000287 AC: 4AN: 139140Hom.: 0 AF XY: 0.0000266 AC XY: 2AN XY: 75148
GnomAD4 exome AF: 0.0000426 AC: 58AN: 1362298Hom.: 0 Cov.: 38 AF XY: 0.0000342 AC XY: 23AN XY: 672190
GnomAD4 genome AF: 0.0000673 AC: 10AN: 148692Hom.: 0 Cov.: 32 AF XY: 0.0000967 AC XY: 7AN XY: 72388
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2021 | The c.17G>A (p.R6Q) alteration is located in exon 2 (coding exon 1) of the TMEM239 gene. This alteration results from a G to A substitution at nucleotide position 17, causing the arginine (R) at amino acid position 6 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at